61 related articles for article (PubMed ID: 23303118)
1. Prevention of HIV Transmission and the HPTN 052 Study.
Cohen MS; Gamble T; McCauley M
Annu Rev Med; 2020 Jan; 71():347-360. PubMed ID: 31652410
[TBL] [Abstract][Full Text] [Related]
2. Adherence to Antiretroviral Therapy for the Success of Emerging Interventions to Prevent HIV Transmission: A Wake up Call.
Nachega JB; Uthman OA; Mills EJ; Quinn TC
J AIDS Clin Res; 2013 Oct; 2012(Suppl 4):. PubMed ID: 24032088
[TBL] [Abstract][Full Text] [Related]
3. The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics.
Wilson DP; Coplan PM; Wainberg MA; Blower SM
Proc Natl Acad Sci U S A; 2008 Jul; 105(28):9835-40. PubMed ID: 18606986
[TBL] [Abstract][Full Text] [Related]
4. Experience in international clinical research: the HIV Prevention Trials Network.
Sista ND; Abdool Karim Q; Hinson K; Donnell D; Eshleman SH; Vermund SH
Clin Investig (Lond); 2011 Dec; 1(12):1609-1618. PubMed ID: 22348195
[TBL] [Abstract][Full Text] [Related]
5. Microbicides and HIV: A Review and an update.
Naswa S; Marfatia YS; Prasad TL
Indian J Sex Transm Dis AIDS; 2012 Jul; 33(2):81-90. PubMed ID: 23188931
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of the quality of trials evaluating biomedical HIV prevention interventions shows that many lack power.
Graham SM; Shah PS; Aesch ZC; Beyene J; Bayoumi AM
HIV Clin Trials; 2009; 10(6):413-31. PubMed ID: 20133272
[TBL] [Abstract][Full Text] [Related]
7. Protection Efficacy of C5A Against Vaginal and Rectal HIV Challenges in Humanized Mice.
Gallay PA; Chatterji U; Kirchhoff A; Gandarilla A; Pyles RB; Baum MM; Moss JA
Open Virol J; 2018; 12():1-13. PubMed ID: 29541273
[TBL] [Abstract][Full Text] [Related]
8. Recent key advances in human immunodeficiency virus medicine and implications for China.
Sun K; Zhou S; Chen RY; Cohen MS; Zhang F
AIDS Res Ther; 2010 May; 7():12. PubMed ID: 20500898
[TBL] [Abstract][Full Text] [Related]
9. Demographic characteristics associated with the use of HIV pre-exposure prophylaxis (PrEP) in an urban, community health center.
Caponi M; Burgess C; Leatherwood A; Molano LF
Prev Med Rep; 2019 Sep; 15():100889. PubMed ID: 31194089
[TBL] [Abstract][Full Text] [Related]
10. Using Contact Patterns to Inform HIV Interventions in Persons Who Inject Drugs in Northern Vietnam.
Smith MK; Graham M; Latkin CA; Go VL
J Acquir Immune Defic Syndr; 2018 May; 78(1):1-8. PubMed ID: 29389769
[TBL] [Abstract][Full Text] [Related]
11. Integration of Social, Cultural, and Biomedical Strategies into an Existing Couple-Based Behavioral HIV/STI Prevention Intervention: Voices of Latino Male Couples.
Martinez O; Wu E; Levine EC; Muñoz-Laboy M; Fernandez MI; Bass SB; Moya EM; Frasca T; Chavez-Baray S; Icard LD; Ovejero H; Carballo-Diéguez A; Rhodes SD
PLoS One; 2016; 11(3):e0152361. PubMed ID: 27028873
[TBL] [Abstract][Full Text] [Related]
12. Implementation challenges and opportunities for HIV Treatment as Prevention (TasP) among young men in Vancouver, Canada: a qualitative study.
Knight R; Small W; Thomson K; Gilbert M; Shoveller J
BMC Public Health; 2016 Mar; 16():262. PubMed ID: 26975718
[TBL] [Abstract][Full Text] [Related]
13. A scoping study to identify opportunities to advance the ethical implementation and scale-up of HIV treatment as prevention: priorities for empirical research.
Knight R; Small W; Pakula B; Thomson K; Shoveller J
BMC Med Ethics; 2014 Jul; 15():54. PubMed ID: 24994501
[TBL] [Abstract][Full Text] [Related]
14. Biomedical strategies for human immunodeficiency virus (HIV) prevention? A new paradigm.
Chan R
Ann Acad Med Singap; 2012 Dec; 41(12):595-601. PubMed ID: 23303118
[TBL] [Abstract][Full Text] [Related]
15. The promise of pre-exposure prophylaxis with antiretroviral drugs to prevent HIV transmission: a review.
Hankins CA; Dybul MR
Curr Opin HIV AIDS; 2013 Jan; 8(1):50-8. PubMed ID: 23201856
[TBL] [Abstract][Full Text] [Related]
16. Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa.
van der Straten A; Stadler J; Luecke E; Laborde N; Hartmann M; Montgomery ET;
J Int AIDS Soc; 2014; 17(3 Suppl 2):19146. PubMed ID: 25224610
[TBL] [Abstract][Full Text] [Related]
17. HIV microbicides: where are we now?
Quiñones-Mateu ME; Vanham G
Curr HIV Res; 2012 Jan; 10(1):1-2. PubMed ID: 22264039
[TBL] [Abstract][Full Text] [Related]
18. Clinical development of microbicides for the prevention of HIV infection.
D'Cruz OJ; Uckun FM
Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
[TBL] [Abstract][Full Text] [Related]
19. Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception.
Heffron R; Mugo N; Were E; Kiarie J; Bukusi EA; Mujugira A; Frenkel LM; Donnell D; Ronald A; Celum C; Baeten JM;
AIDS; 2014 Nov; 28(18):2771-6. PubMed ID: 25493602
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
